147 related articles for article (PubMed ID: 34017965)
1. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.
Singh P; Scoggins ME; Sahin AA; Hwang RF; Kuerer HM; Caudle AS; Mittendorf EA; Thompson AM; Bedrosian I; Teshome M; DeSnyder SM; Meric-Bernstam F; Hunt KK
Ann Surg Open; 2020 Dec; 1(2):e008. PubMed ID: 34017965
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience of the Magseed
Crèvecoeur J; Jossa V; Di Bella J; Coibion M; Crèvecoeur A
Gland Surg; 2023 May; 12(5):566-576. PubMed ID: 37284712
[TBL] [Abstract][Full Text] [Related]
3. Multicentre evaluation of magnetic technology for localisation of non-palpable breast lesions and targeted axillary nodes.
McCamley C; Ruyssers N; To H; Tsao S; Keane H; Poliness C; Mehta K; Rose A; Baker C; Mann GB
ANZ J Surg; 2021 Nov; 91(11):2411-2417. PubMed ID: 34405514
[TBL] [Abstract][Full Text] [Related]
4. Initial experience of magnetic seed localization for impalpable breast lesion excision: First 100 cases performed in a single Irish tertiary referral centre.
Murphy E; Quinn E; Stokes M; Kell M; Barry M; Flanagan F; Walsh SM
Surgeon; 2022 Jun; 20(3):e36-e42. PubMed ID: 33840595
[TBL] [Abstract][Full Text] [Related]
5. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
Micha AE; Sinnett V; Downey K; Allen S; Bishop B; Hector LR; Patrick EP; Edmonds R; Barry PA; Krupa KDC; Rusby JE
Breast Cancer; 2021 Jan; 28(1):196-205. PubMed ID: 32974810
[TBL] [Abstract][Full Text] [Related]
6. A prospective, single-arm, multicentre clinical evaluation of a new localisation technique using non-radioactive Magseeds for surgery of clinically occult breast lesions.
Thekkinkattil D; Kaushik M; Hoosein MM; Al-Attar M; Pilgrim S; Gvaramadze A; Hyklova L; Jibril A
Clin Radiol; 2019 Dec; 74(12):974.e7-974.e11. PubMed ID: 31563293
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Accuracy of Using Magnetic Seed for Preoperative Non-Palpable Breast Lesions Localization: Our Experience with Magseed.
D'Angelo A; Trombadori CML; Caprini F; Lo Cicero S; Longo V; Ferrara F; Palma S; Conti M; Franco A; Scardina L; D'Archi S; Belli P; Manfredi R
Curr Oncol; 2022 Nov; 29(11):8468-8474. PubMed ID: 36354727
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the nonradioactive inducible magnetic seed system Magseed for preoperative localization of nonpalpable breast lesions - initial clinical experience.
Pieszko K; Wichtowski M; Cieciorowski M; Jamont R; Murawa D
Contemp Oncol (Pozn); 2020; 24(1):51-54. PubMed ID: 32514238
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.
Powell M; Gate T; Kalake O; Ranjith C; Pennick MO
Breast J; 2021 Jun; 27(6):529-536. PubMed ID: 33855763
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial.
Žatecký J; Kubala O; Coufal O; Kepičová M; Faridová A; Rauš K; Lerch M; Peteja M; Brát R
Breast Care (Basel); 2021 Aug; 16(4):383-388. PubMed ID: 34602944
[TBL] [Abstract][Full Text] [Related]
11. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
Zacharioudakis K; Down S; Bholah Z; Lee S; Khan T; Maxwell AJ; Howe M; Harvey J
Eur J Surg Oncol; 2019 Nov; 45(11):2016-2021. PubMed ID: 31288944
[TBL] [Abstract][Full Text] [Related]
12. Wireless localisation of breast lesions with MagSeed. A radiological perspective of 300 cases.
Constantinidis F; Sakellariou S; Chang SL; Linder S; MacPherson B; Seth S; Gill N; Seth A
Br J Radiol; 2022 May; 95(1133):20211241. PubMed ID: 35201906
[TBL] [Abstract][Full Text] [Related]
13. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study.
Harvey JR; Lim Y; Murphy J; Howe M; Morris J; Goyal A; Maxwell AJ
Breast Cancer Res Treat; 2018 Jun; 169(3):531-536. PubMed ID: 29453521
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
Liang DH; Black D; Yi M; Luo CK; Singh P; Sahin A; Scoggins ME; Moseley TW; Hunt KK
Ann Surg Oncol; 2022 Jun; 29(6):3822-3828. PubMed ID: 35233742
[TBL] [Abstract][Full Text] [Related]
15. Evolving Role of Magseed in Wireless Localization of Breast Lesions: Systematic Review and Pooled Analysis of 1,559 Procedures.
Gera R; Tayeh S; Al-Reefy S; Mokbel K
Anticancer Res; 2020 Apr; 40(4):1809-1815. PubMed ID: 32234869
[TBL] [Abstract][Full Text] [Related]
16. Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions.
Look Hong N; Wright FC; Semple M; Nicolae AM; Ravi A
Breast Cancer Res Treat; 2020 Feb; 179(3):671-676. PubMed ID: 31754951
[TBL] [Abstract][Full Text] [Related]
17. SAVI Scout® System for Excision of Non-Palpable Breast Lesions.
Farha MJ; Simons J; Kfouri J; Townsend-Day M
Am Surg; 2023 Jun; 89(6):2434-2438. PubMed ID: 35509218
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the use of the Magseed marker in the localization of non-palpable lesions in the mammary gland.
Cieciorowski M; Wow T; Cieśla S; Kolacinska A; Murawa D
Pol Przegl Chir; 2022 Oct; 95(4):1-5. PubMed ID: 36807097
[TBL] [Abstract][Full Text] [Related]
19. Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.
Bravo EI; Martínez AM; Alvà HP; Sancho DR; López JCA; Sánchez JA; Casa PE; de Las Heras CG; Venegas MAF; Vidal EG; Begines ED; Mur CG; Vicente I; Casamayor C; Cruz S; Barrado AG
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38898360
[TBL] [Abstract][Full Text] [Related]
20. Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study.
Morgan JL; Bromley HL; Dave RV; Masannat Y; Masudi T; Mylvaganam S; Elgammal S; Barnes N; Down S; Holcombe C; Potter S; Gardiner MD; Maxwell AJ; Somasundaram SK; Sami A; Kirwan C; Harvey J;
Eur J Surg Oncol; 2022 Dec; 48(12):2408-2413. PubMed ID: 36068125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
